ERIC MESSNER

Senior Vice President, Commercial

Eric Messner serves as Senior Vice President of Commercial at Paragon Biosciences. He advises early-stage portfolio companies on their commercial operations and completes due diligence for new investment opportunities. Mr. Messner is also General Manager of Emalex Biosciences, where he oversees operational activities while the company conducts clinical trials.

Mr. Messner’s previous role at Paragon Biosciences was Senior Vice President of Portfolio Management, where he was part of the team evaluating new business opportunities.

Mr. Messner has had a long and successful career in the pharmaceutical industry. Formerly, he was Marathon Pharmaceutical’s Vice President of Sales and Marketing, where he led sales, marketing and managed-care strategy and execution. Before that, Mr. Messner was CEO of Anagin, which develops drugs for post-traumatic stress disorder and traumatic brain injury. Mr. Messner also served as General Manager & Executive Vice President of Sales and Marketing for OPKO Health, where he had commercial responsibility for the renal division and urology laboratory division. Earlier in his career, he was a founder and Vice President of Marketing and Commercial Operations of Proventiv Therapeutics, which was acquired by Cytochroma. At Cytochroma, he was Vice President of Commercial Operations and later the Chief Operating Officer and helped lead the sale of Cytochroma to OPKO Health. Mr. Messner also previously held senior marketing roles at Bone Care International and Abbott Laboratories.

Mr. Messner earned his MBA from J.L. Kellogg Graduate School of Management at Northwestern University and his Bachelor of Science in Business Administration from Miami University.